| 4 | Private Advisor Group, LLC | 197K | $2.3M | +13.1% | 0.058% | 0.01% |
| 5 | MARSHALL WACE, LLP | 189K | $2.2M | — | 0.056% | 0.00% |
| 6 | MORGAN STANLEY | 166K | $1.9M | +42.5% | 0.049% | 0.00% |
| 7 | Integrated Wealth Concepts LLC | 164K | $1.9M | 0.0% | 0.049% | 0.01% |
| 8 | UBS Group AG | 135K | $1.6M | +317.0% | 0.040% | 0.00% |
| 9 | BLAIR WILLIAM & CO/IL | 123K | $1.4M | — | 0.036% | 0.00% |
| 10 | Raiffeisen Bank International AG | 115K | $1.3M | -11.5% | 0.034% | 0.02% |
| 11 | Quadrature Capital Ltd | 102K | $1.2M | — | 0.030% | 0.01% |
| 12 | JPMORGAN CHASE & CO | 78K | $876K | +35.2% | 0.023% | 0.00% |
| 13 | XY Capital Ltd | 71K | $822K | +468.0% | 0.021% | 0.79% |
| 14 | XTX Topco Ltd | 69K | $793K | +164.5% | 0.020% | 0.01% |
| 15 | Vanguard Personalized Indexing Management, LLC | 59K | $680K | +77.4% | 0.017% | 0.01% |
| 16 | NLB Skladi, upravljanje premozenja, d.o.o. | 58K | $669K | — | 0.017% | 0.03% |
| 17 | Mariner, LLC | 37K | $428K | -14.6% | 0.011% | 0.00% |
| 18 | Capricorn Fund Managers Ltd | 36K | $416K | — | 0.011% | 0.03% |
| 19 | GTS SECURITIES LLC | 36K | $410K | — | 0.011% | 0.01% |
| 20 | JANE STREET GROUP, LLC | 33K | $385K | — | 0.010% | 0.00% |
| 21 | IHT Wealth Management, LLC | 32K | $372K | +29.0% | 0.009% | 0.01% |
| 22 | SummitTX Capital, L.P. | 32K | $365K | — | 0.009% | 0.01% |
| 23 | Portolan Capital Management, LLC | 25K | $293K | -95.3% | 0.007% | 0.01% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 21K | $237K | +71.0% | 0.006% | 0.00% |
| 25 | HSBC HOLDINGS PLC | 16K | $190K | — | 0.005% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in TLX — a direct measure of their conviction.
| 0.01% |
| +0.01 pp |
| $1M |
| +1290% |
| Q4 2024 | 2 | +100% | 0.00% | — | $0M | — |
| Q2 2024 | 1 | — | — | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
TLX institutional ownership rose by 0.13 percentage points quarter-over-quarter, with a net change of +22 holders.
The top 10 institutions account for 73.6% of all reported 13F value in TLX, and the top 25 account for 97.2%.
Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.